The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis

Background: The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial aimed to determine whether or not oral Δ9-tetrahydrocannabinol (Δ9-THC) slowed the course of progressive multiple sclerosis (MS); evaluate safety of cannabinoid administration; and, improve methods for testing tr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Susan Ball, Jane Vickery, Jeremy Hobart, Dave Wright, Colin Green, James Shearer, Andrew Nunn, Mayam Gomez Cano, David MacManus, David Miller, Shahrukh Mallik, John Zajicek
Format: Artigo
Langue:Inglês
Publié: NIHR Journals Library 2015-02-01
Collection:Health Technology Assessment
Sujets:
multiple sclerosis
cannabinoids
dronabinol
magnetic resonance imaging
randomised controlled trial
cupid trial
Accès en ligne:https://doi.org/10.3310/hta19120
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires